Internal Medicine, Rheumatology · New Hartford, NY
NPI
1811990997
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4401 Middle Settlement Rd, Suite 106
New Hartford, NY, 13413
Phone (315) 724-5333
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
60,950 services
Medicare patients, 2024
426
Average age 73
Drug cost, 2024
$6.1M
4,660 prescriptions
Company payments, 2025
$3,343
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin Morell was code J0129 (injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 13,150 times for 18 patients. In total Martin Morell billed 60,950 services in 30 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 13,150 | 18 | $33.96 | $447K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,669 | 13 | $8.51 | $91K |
| J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 1,055 | 27 | $13.69 | $14K |
| 99214 Office E&M - Established | Office | 794 | 357 | $90.96 | $72K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 402 | 264 | $11.78 | $4,735 |
| 96413 Chemotherapy Administration | Office | 341 | 44 | $96.02 | $33K |
| 99213 Office E&M - Established | Office | 312 | 164 | $65.71 | $21K |
| 92548 Test - Miscellaneous | Office | 282 | 279 | $35.61 | $10K |
| 20610 Joint Injection | Office | 174 | 60 | $40.36 | $7,022 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 108 | 35 | $0.72 | $78.28 |
| 99204 Office E&M - New | Office | 80 | 80 | $118.22 | $9,458 |
By year: 2022 $927K for 51,835 services; 2023 $920K for 58,027 services; 2024 $1.0M for 60,950 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martin Morell prescribed most often to Medicare patients was Tizanidine Hcl, with 598 prescriptions and refills. In total Martin Morell wrote 4,660 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tizanidine Hcl Generic | 598 | 853 | 126 | $4,333 |
| Gabapentin Generic | 404 | 510 | 82 | $4,982 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 388 | 394 | 47 | $8,183 |
| Prednisone Generic | 315 | 397 | 108 | $1,468 |
| Methotrexate Methotrexate Sodium | 294 | 561 | 61 | $6,188 |
| Tramadol Hcl Generic | 213 | 243 | 38 | $1,462 |
| Celecoxib Generic | 192 | 278 | 44 | $2,827 |
| Meloxicam Generic | 170 | 252 | 49 | $430 |
| Allopurinol Generic | 144 | 322 | 36 | $1,572 |
| Humira(Cf) Pen Adalimumab | 141 | 206 | 21 | $1.4M |
| Zolpidem Tartrate Generic | 136 | 136 | 17 | $588 |
| Pregabalin Generic | 129 | 195 | 25 | $5,897 |
| Xeljanz Xr Tofacitinib Citrate | 125 | 171 | 19 | $952K |
| Rinvoq Upadacitinib | 90 | 141 | 19 | $888K |
| Leflunomide Generic | 82 | 181 | 21 | $4,967 |
Brand drugs: 724 claims; generic drugs: 3,936 claims; opioid claims: 741.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin Morell $3,343 ($3,343 in general payments such as food, travel and fees) from 22 companies. The largest payer was UCB, Inc. with $615.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 20 | $615 |
| Janssen Biotech, Inc. JNJ | 15 | $615 |
| Abbvie Inc. ABBV | 23 | $336 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $279 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $258 |
| Pfizer Inc. PFE | 11 | $221 |
| Genentech USA, Inc. ROG.SW | 9 | $159 |
| Lilly USA, LLC LLY | 3 | $153 |
| Mallinckrodt Hospital Products Inc. | 4 | $137 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $134 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.